Sara Franzi | Biology Transplantology | Women Researcher Award

Published on by World Top Scientists

Dr. Sara Franzi | Biology Transplantology | Women Researcher Award

Researcher | Policlinico of Milan | Italy

Dr. Sara Franzi is a Researcher at the IRCCS Ca’ Granda Ospedale Maggiore Policlinico in Milan, specializing in transplantation biology and biomedical research. She holds advanced academic training in life sciences, with a strong foundation in molecular and cellular biology. Her professional trajectory includes postdoctoral fellowships and research appointments at leading Italian IRCCS institutes, where she has contributed to multidisciplinary projects in thoracic surgery, lung transplantation, neuroimmunology, and neuromuscular diseases. Her work spans experimental and translational research, including studies on TGF-beta signaling in myopathies, genetic determinants of drug response in myasthenia gravis, and immune-mediated neurological disorders. She has demonstrated leadership in coordinating research initiatives and contributes to scientific dissemination as a medical writer and reviewer for peer-reviewed journals. Dr. Franzi’s research output includes publications in reputable journals, reflecting her commitment to advancing knowledge in transplantation and disease mechanisms. Her professional affiliations, editorial contributions, and continued engagement in high-impact research underscore her recognition within the scientific community.

Citation Metrics (Google Scholar)

392
300
200
100
0

392

11

10

Citations

Documents

h-index


Top 5 Featured Publications

 

Jeimylo De Castro| Medicine and Dentistry | Research Excellence Award

Published on by World Top Scientists

Prof. Dr. Jeimylo De Castro| Medicine and Dentistry | Research Excellence Award

Medical Director | SMARTMD | Philippines

Prof. Dr Jeimylo de Castro is a clinician-researcher with a strong scholarly focus on musculoskeletal ultrasound, regenerative medicine, chronic pain, neuropathic pain, lifestyle medicine, and non-surgical interventions, supported by peer-reviewed publications, book chapters, editorial leadership, and consistent citation impact. Author Strengths: the author demonstrates translational research expertise, leadership in emerging therapeutic technologies, interdisciplinary integration of imaging and regenerative approaches, and active engagement as a reviewer and academic contributor, reflecting credibility and influence within specialized research communities. Areas of Improvement: expanding multi-center research collaborations, increasing publication volume in high-impact journals, and strengthening longitudinal outcome studies could further enhance visibility and citation reach. Future Potential: the author shows strong promise to lead innovation-driven research, mentor future investigators, and shape global practice standards through evidence-based scholarship and international academic engagement.

 

Citation Metrics (Google Scholar)

14
10
7
4
0

14

12

2

Citations

Documents

h-index

Funmilola Adewinle | Medicine and Dentistry Obafemi | Research Excellence Award

Published on by World Top Scientists

Dr. Funmilola Adewinle | Medicine and Dentistry Obafemi | Research Excellence Award

Consultant | Awolowo University Teaching Hospital | Nigeria

Dr. Funmilola Eunice Adewinle is a Consultant at the Obafemi Awolowo University Teaching Hospital, Ile-Ife, with recognized expertise in oral medicine, orofacial pain, and headache disorders. She holds a Bachelor’s degree in Dentistry and Dental Surgery, a Master’s degree in Public Health, and a Fellowship in Oral Medicine, and is completing advanced doctoral training in orofacial pain. Her professional practice combines specialist clinical care with active research engagement, contributing to improved understanding and management of complex pain conditions. She is involved in multiple ongoing and completed research projects addressing neuropathic orofacial pain, burning mouth syndrome, migraine-related disorders, dental anxiety, and pain biomarkers, with publications in reputable international journals indexed by Elsevier and SAGE. Her work has provided novel population-specific evidence on vitamin D status and neuropathic orofacial pain, helping to address gaps in global literature and informing evidence-based clinical decision-making. Dr. Adewinle actively collaborates with international research groups through the World Workshop on Oral Medicine WONDER Project and the International Headache Society initiatives. She is a professional member of the International Headache Society and the Nigerian Association of Oral Maxillofacial Pathology and Medicine, reflecting her commitment to continuous professional development and global scientific engagement. Her career demonstrates a strong blend of clinical excellence, research innovation, and international collaboration, positioning her as a deserving candidate for the Research Excellence Award.

Profiles: ORCID

Featured Publications

1. Adewinle, F. E., Owotade, F. J., Komolafe, M. A., Adedeji, T. A., Oyetola, E. O., Adekanmbi, O. G., & Olukoyejo, O. E. (2025). Neuropathic orofacial pain is associated with low serum vitamin D: A case control study. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.

2. Mascarella, D., Zhuang, Z. A., Gliga, O., De Santis, F., Rosignoli, C., Daputke, A., Njohjam, M. N., Mazzotta, E., Adewinle, F. E., Caronna, E., et al. (2025). Migraine in monogenic disorders: Shedding light on new therapeutic targets. Cephalalgia.

Dr. Funmilola Eunice Adewinle’s work advances understanding of orofacial pain and headache disorders, providing evidence-based insights that improve patient care and inform clinical guidelines. Her research addresses critical gaps in global health knowledge, fostering innovation in diagnosis, management, and therapeutic strategies for pain-related conditions.

Kartik Bhatia | Medicine and Dentistry | Research Excellence Award

Published on by World Top Scientists

Assoc. Prof. Dr. Kartik Bhatia | Medicine and Dentistry | Research Excellence Award 

Clinical Associate Professor | University of Sydney | Australia

Associate Professor Dr. Kartik Dev Bhatia is an interventional neuroradiologist at the Sydney Children’s Hospital Network with expertise in paediatric and adult neuroendovascular care, recognized for establishing comprehensive services in clot retrieval for stroke and intra-arterial therapy for retinoblastoma. He holds a PhD and advanced clinical qualifications including subspecialty recognition in interventional neuroradiology, fellowship of the Royal Australian and New Zealand College of Radiologists, and dual medical and surgical degrees, underpinning a strong academic and clinical foundation. His professional experience spans leadership of multidisciplinary cerebrovascular programs, major fellowships across leading Australian and international centres, and service as a staff specialist and consultant interventional neuroradiologist across multiple tertiary hospitals. Dr. Bhatia’s research focuses on paediatric neurointervention, stroke, vascular malformations, and innovative endovascular therapies, with influential publications in high-impact journals and contributions to key international registries. He has authored multiple book chapters and serves as a reviewer for prominent journals in neuroradiology, neurology, and stroke medicine, reflecting his standing in the academic community. His work has advanced understanding of paediatric cerebrovascular disease, liquid biopsy applications in vascular malformations, and endovascular treatment paradigms. A recipient of distinctions including a Research Excellence Award, he also contributes through editorial activities, scholarly mentorship, and active membership in multidisciplinary and professional bodies. Dr. Bhatia’s blend of clinical innovation, academic leadership, and sustained research impact positions him as an outstanding candidate for recognition.

Citation Metrics (Google Scholar)

1500
1000
500
0

1409
Citations

22
h-index

30
i10-index


View Google Scholar Profile

Top Publications

Feyera Gemeda | Infectious Diseases | Outstanding Scientist Award

Published on by World Top Scientists

Assoc. Prof. Dr. Feyera Gemeda | Infectious Diseases | Outstanding Scientist Award

Associate Professor | Dima Jimma university | Ethiopia

Assoc. Prof. Dr. Feyera Gemeda Dima is a distinguished researcher and academic with extensive experience in Infectious Diseases, Medical Mycology, and Medicine. He has demonstrated excellence in teaching, research, and mentorship at both national and international levels, fostering the development of students and early-career researchers. His work emphasizes innovation in scientific research, editorial contributions, and leadership in grant assessment and curriculum development. He has contributed significantly to global collaborations and serves as a Chief Scientist and Global Assessor, reflecting his commitment to advancing scientific knowledge. His research focuses on improving understanding and management of infectious diseases, with the potential to influence public health strategies. Prof. Gemeda’s dedication to integrating innovative approaches and interdisciplinary perspectives underscores his capacity for impactful contributions in the field.

Profile:  Google Scholar

Featured Publications

1. T. Gizaw and F. G. Dima, “Assessment of problems and constraints associated with artificial insemination service in the two selected districts of Arsi zone,” Journal of Harmonized Research in Medical and Health Sciences, vol. 3, no. 1, pp. 14–37, 2016.

2. A. Edao, F. G. Dima, and F. B. Deressa, “Prevalence of bovine cysticercosis and status of human taeniasis in and around Asella town, Tiyoworeda, south east Ethiopia,” Glob J Med Res, vol. 16, pp. 18–26, 2016.

3. F. Gemeda, “Prevalence of bovine Trypanosomosis in and around Nekemte areas, east Wollega zone, Ethiopia,” Open Access Library Journal, vol. 2, no. 05, p. 1, 2015.

4. D. T. Legesse and F. Gemeda, “Comparison of two parasitological tests and post mortem examination to detect prevalence of bovine fasciolosis at Ambo Town Municipal Abattoir, West Shewa Zone, Ethiopia,” Open Access Library Journal, vol. 2, no. 8, pp. 1–5, 2015.

5. F. G. Dima and T. Fikedu, “Review on infectious bovine keratoconjunctivitis,” J Bacteriol Infect Dis, vol. 4, no. 4, pp. 1–6, 2021.

Dr. Gemeda’s work advances the understanding and control of infectious diseases, providing evidence-driven insights that strengthen public health systems and guide global disease management strategies.

Javad Amini Mahabadi | Medicine and Dentistry | Editorial Board Member

Published on by World Top Scientists

Dr. Javad Amini Mahabadi | Medicine and Dentistry | Editorial Board Member

Javad Amini Mahabadi  | Kashan University of Medical Sciences | Iran

Dr. Javad Amini Mahabadi, a reproductive biologist and faculty member at Kashan University of Medical Sciences, is recognized for his expertise in reproductive biology, IVF, and stem-cell–based approaches to fertility science. He holds advanced degrees culminating in a Ph.D. in Reproductive Biology, with specialized training in assisted reproductive technologies and cellular therapeutics. His professional experience includes leading laboratory initiatives in gamete and embryo research, contributing to multidisciplinary reproductive health projects, mentoring emerging scientists, and supporting institutional development through academic and committee service. Dr. Amini Mahabadi’s research focuses on reproductive physiology, embryo development, and innovative stem-cell applications, reflected in a substantial body of peer-reviewed publications and a strong citation record demonstrating sustained scientific impact. His contributions extend to methodological advancements and collaborative work aimed at improving clinical and translational outcomes in reproductive medicine. He has received institutional and professional recognitions for research excellence, serves in editorial and peer-review roles for respected journals, and maintains active membership in scientific societies that promote reproductive health and biomedical innovation.

Profiles: Google Scholar

Featured Publications

1. Mohammadi, F., Nikzad, H., Taherian, A., Amini Mahabadi, J., & Salehi, M. (2013). Effects of herbal medicine on male infertility. Anatomical Sciences Journal, 10(4), 3–16.

2. Aghaei, S., Nikzad, H., Taghizadeh, M., Tameh, A. A., Taherian, A., & Moravveji, A. (2014). Protective effect of pumpkin seed extract on sperm characteristics, biochemical parameters and epididymal histology in adult male rats treated with cyclophosphamide. Andrologia, 46(8), 927–935.

3. Abazari, M. F., Soleimanifar, F., Aleagha, M. N., Torabinejad, S., Nasiri, N., … (2018). PCL/PVA nanofibrous scaffold improve insulin-producing cells generation from human induced pluripotent stem cells. Gene, 671, 50–57.

4. Abazari, M. F., Soleimanifar, F., Amini Faskhodi, M., Mansour, R. N., … (2020). Improved osteogenic differentiation of human induced pluripotent stem cells cultured on polyvinylidene fluoride/collagen/platelet-rich plasma composite nanofibers. Journal of Cellular Physiology, 235(2), 1155–1164.

5. Tahmasebi, A. T., Enderami, S. E., Saburi, E., Islami, M., … (2019). MicroRNA incorporated electrospun nanofibers improve osteogenic differentiation of human induced pluripotent stem cells. Journal of Biomedical Materials Research, 108(2), 377–386.

Dr. Javad Amini Mahabadi’s work advances reproductive biology and stem-cell–based innovation, contributing to improved fertility outcomes and translational biomedical solutions. His research supports scientific progress, strengthens clinical practices, and fosters technologies that enhance public health and future therapeutic development.

Milad Shirvaliloo | Cancer Epigenetics | Best Researcher Award 

Published on by World Top Scientists

Dr. Milad Shirvaliloo | Cancer Epigenetics | Best Researcher Award 

Research Associate | Iran University of Medical Sciences | Iran

Dr. Milad Shirvaliloo is an accomplished physician–researcher specializing in epigenetics with a focus on cancer and pulmonary medicine. Holding a Doctor of Medicine and a Master of Business Administration in Health Sciences, he combines clinical expertise with research innovation to advance precision medicine. As a Postgraduate Researcher at the Finetech in Medicine Research Center, he leads studies on nanoparticle-based therapeutic interventions and their effects on histone acetylation in cancer. Dr. Shirvaliloo has authored more than forty peer-reviewed publications and a book chapter, contributing extensively to understanding molecular and epigenetic mechanisms in disease pathogenesis. His scholarly output includes first-author and single-author papers in leading journals, where he explores the roles of histone modifications, long noncoding RNAs, and nanobiosensor technologies in diagnostics and therapeutics. He has demonstrated academic leadership as an Editorial Board Member for Epigenomics and Molecular and Cellular Biochemistry and has served as a peer reviewer for over sixty high-impact journals. Recognized for his scientific excellence and editorial contributions, he has received the Best Researcher Award for his outstanding achievements in biomedical science. His ongoing work reflects a strong commitment to translational research, interdisciplinary collaboration, and mentorship of emerging scientists. With a clear vision for integrating molecular biology, nanotechnology, and clinical application, Dr. Shirvaliloo exemplifies the future of innovative medical research and continues to make significant contributions to global health advancement.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Heris, R. M., Shirvaliloo, M., Abbaspour-Aghdam, S., Hazrati, A., Shariati, A., & others. (2022). The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment. Stem Cell Research & Therapy, 13(1), 371.

2. Sheervalilou, R., Shirvaliloo, M., Dadashzadeh, N., Shirvalilou, S., Shahraki, O., & others. (2020). COVID‐19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019‐nCoV disease. Journal of Cellular Physiology, 235(12), 8873–8924.

3. Aghbash, P. S., Eslami, N., Shirvaliloo, M., & Baghi, H. B. (2021). Viral coinfections in COVID‐19. Journal of Medical Virology, 93(9), 5310–5322.

4. Shirvalilou, S., Khoei, S., Esfahani, A. J., Kamali, M., Shirvaliloo, M., & others. (2021). Magnetic hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: A systematic review. Journal of Neuro-Oncology, 152(3), 419–428.

5. Razlansari, M., Jafarinejad, S., Rahdar, A., Shirvaliloo, M., Arshad, R., & others. (2023). Development and classification of RNA aptamers for therapeutic purposes: An updated review with emphasis on cancer. Molecular and Cellular Biochemistry, 478(7), 1573–1598.*

Dr. Milad Shirvaliloo’s pioneering research in epigenetics and nanomedicine bridges molecular science with clinical application, driving innovations in cancer and pulmonary disease diagnostics and therapies. His work advances precision medicine and fosters global scientific collaboration, contributing to more effective, personalized healthcare solutions.

Aneta Guzek | Bloodstream Infections | Best Researcher Award

Published on by World Top Scientists

Dr. Aneta Guzek | Bloodstream Infections | Best Researcher Award

Head of Microbial Laboratory | National Research Institute | Poland

Dr. Aneta Guzek is the Head of the Microbiology Laboratory at the Military Institute of Medicine – National Research Institute in Warsaw, Poland, specializing in medical microbiology and laboratory diagnostics. She holds a PhD in medicine with a specialization in medical microbiology from the Military Institute of Medicine, complemented by postgraduate qualifications in medical microbiology from the Medical University of Lublin and innovation management in the health care sector from Kozminski University. Additionally, she earned an MSc in biology with a focus on microbiology from the University of Warsaw and is a certified laboratory diagnostician. Dr. Guzek leads a multidisciplinary team overseeing comprehensive microbiological diagnostics, implementation of advanced diagnostic methods, and the development of institutional policies on infection control and antibiotic stewardship. Her research contributions include studies on antimicrobial resistance, hospital infection control, and the advancement of microbiological procedures, with numerous publications and citations in recognized scientific sources. She collaborates with national and reference laboratories, contributing to public health and medical innovation. Her exemplary service has been recognized with prestigious honors, including the first place in the Hippocrates Medical Poll for Laboratory Diagnostician of the Year and the Badge of Honour from the Military Medical Institute for her efforts during the COVID-19 pandemic. Dr. Guzek also holds certification in Good Clinical Practice (ICH E6 R2), underscoring her commitment to excellence in research and clinical integrity.

Profiles: Scopus | ORCID

Featured Publications

1. Guzek, A., et al. (2025). Microbiological comparison of maxillary sinus rinses in non-odontogenic and odontogenic sinusitis of primarily endodontic origin. Journal of Clinical Medicine.

2. Guzek, A., et al. (2024). Outcomes of 23 patients diagnosed with New Delhi metallo-beta-lactamase (NDM)-producing Klebsiella pneumoniae infection treated with ceftazidime/avibactam and aztreonam at a single center in Poland. Journal of Clinical Medicine.

3. Guzek, A., et al. (2024). Dissemination of extensively drug-resistant NDM-producing Providencia stuartii in Europe linked to patients transferred from Ukraine, March 2022 to March 2023. Eurosurveillance.

Tuba Duzcu | Health Management | Best Researcher Award

Published on by World Top Scientists

Mrs. Tuba Duzcu | Health Management | Best Researcher Award

Asst.Prof. at Istanbul Medipol University, Turkey

Tuba Düzcü is an accomplished academic specializing in health management with a strong interdisciplinary background that spans biology, business administration, and digital media. Currently serving as an Assistant Professor at Istanbul Medipol University, she has made significant contributions through her research on healthcare branding, emotional labor, artificial intelligence, and the metaverse. Her academic output includes peer-reviewed journal articles, international conference presentations, and book chapters, reflecting both scholarly depth and topical relevance. She has also held key academic and administrative roles, demonstrating leadership in curriculum development and quality assurance. Her work bridges theory and practice, with a focus on innovation in healthcare systems. Active in organizing workshops and serving as a moderator and referee, she plays a vital role in academic discourse. With a solid foundation and a growing body of impactful research, Tuba Düzcü stands out as a dedicated scholar and leader in the evolving landscape of health sciences and management.

Professional Profile 

Google Scholar
Scopus Profile

Education

Tuba Düzcü has pursued a multidisciplinary academic path combining science, business, and health management. She earned her PhD in Health Management from Istanbul University, where her dissertation focused on the role of new media in branding health services and products—an early indication of her interest in digital transformation in healthcare. Prior to that, she completed an MS in Business Administration at Beykent University, focusing on organizational communication and personality impacts. Her academic journey began with a BSc in Biology from Istanbul University, equipping her with a foundational understanding of life sciences. This broad educational base allows her to approach health management with a holistic perspective, integrating scientific knowledge with managerial and strategic insights. Her academic credentials also reflect a commitment to interdisciplinary thinking, a valuable asset in today’s complex and evolving healthcare landscape. Each stage of her education supports her current research in healthcare innovation, media, ethics, and organizational behavior.

Experience

Tuba Düzcü has a robust professional background that blends academic leadership with industry practice. She is currently serving as an Assistant Professor in the Faculty of Health Sciences at Istanbul Medipol University, where she previously held roles as a Research and Teaching Assistant. Earlier in her career, she held similar academic positions at Istanbul Okan University, supporting both education and research activities in vocational health programs. Beyond academia, she gained industry experience in pharmaceutical marketing and management at companies such as BIOFARMA, World Medicine Rotapharm, Dem Pharmaceuticals, and Labsan, working as a medical representative, product manager, and marketing manager. These roles enriched her understanding of healthcare operations, branding, and strategic communication in real-world settings. Additionally, she has held leadership roles in academic committees related to quality assurance, curriculum development, and double-major programs. Her experience bridges the gap between classroom, research, and the health sector, making her well-versed in both theoretical frameworks and applied solutions.

Research Focus on Health Management

Tuba Düzcü’s research is centered on healthcare management, with a strong emphasis on digital innovation, media influence, and organizational behavior. She explores how emerging technologies such as artificial intelligence and the metaverse are reshaping healthcare delivery and workforce dynamics. Her work includes studies on emotional labor, burnout in IVF laboratories, technology acceptance models in patients, and AI in strategic human resources. She has also examined branding in pharmaceutical services and ethical considerations in psychiatry from a managerial standpoint. Her research often uses interdisciplinary methods, merging concepts from communication, psychology, business, and health sciences. Through her academic publications, conference papers, and book chapters, she contributes to contemporary discussions on healthcare marketing, institutional reputation, and digital transformation. Her studies are both theory-driven and application-oriented, aiming to address real-world challenges in health systems. Tuba’s research demonstrates a consistent focus on how innovation and ethics intersect in health management, reflecting societal and organizational needs.

Award and Honor

While specific awards or honors are not directly listed in the available documentation, Tuba Düzcü’s academic achievements and leadership roles reflect a recognized and respected status in her field. Her repeated involvement as a committee chair, moderator, and referee in national and international academic events signifies peer recognition and trust in her expertise. She has been entrusted with key roles in health sector workshops, panel moderation, and certificate programs led by the Turkish Ministry of Health. Her contributions to various academic books and conference proceedings also highlight her prominence in academic circles. Being repeatedly invited to speak, write, and organize scientific activities indicates her standing as a valued thought leader. Although formal awards may not be noted, her impact and credibility are evident through her academic responsibilities, collaborative research roles, and invitations to participate in strategic educational initiatives within health sciences.

Publications Top Notes

  • Title: Kişilik Özelliklerinin Örgütsel İletişime Etkisi ve Bir Araştırma
    Authors: Tuba Erkoç
    Year: 2008
    Citations: 14

  • Title: Artificial Intelligence in IVF Laboratories: Elevating Outcomes Through Precision and Efficiency
    Authors: Yaling Hew, Duygu Kutuk, Tuba Düzcü, Yagmur Ergun
    Year: 2024
    Citations: 8

  • Title: Hastanelerde stratejik insan kaynakları yönetim süreçlerinde yapay zekâ uygulamaları
    Authors: Tuba Düzcü, Veli Bayram, Emel Önder
    Year: 2024
    Citations: 4

  • Title: The perceived service quality on patient: evidence from university hospital
    Authors: Tuba Düzcü, Osman Yıldırım, Hakan Zülfikar, Elif Yılmaz Alarçin, B. Sezginer, H. Tozan
    Year: 2019
    Citations: 4

  • Title: Sağlık Hizmet ve Ürünlerinin Markalanmasında Yeni Medyanın Yeri
    Authors: Tuba Düzcü
    Year: 2019
    Citations: 4

  • Title: Ürün Tanıtım Temsilcilerinin Yeterlilik Eğitimindeki Başarı Düzeylerinin Demografik Özellikleriyle Karşılaştırılması
    Authors: Tuba Düzcü, M. Akyol, O. Sancar
    Year: 2017
    Citations: 2

  • Title: The relationship between health professionals perceptions of innovative work behavior and their metaverse knowledge and awareness levels
    Authors: Tuba Düzcü
    Year: 2025
    Citations: 1

  • Title: İlaç ve Hastane Tercihinde yeni Medya Etkinlik Analizi
    Authors: Tuba Düzcü
    Year: 2023
    Citations: 1

  • Title: Health Professionals’ Perspective in the Context of Social Media, Paranoia, and Working Autonomy During the COVID-19 Pandemic Period
    Authors: Tuba Düzcü, Y. Demir Uslu
    Year: 2023
    Citations: 1

  • Title: The burnout: a silent saboteur in in vitro fertilization laboratories
    Authors: M. Basar, Tuba Düzcü
    Year: 2025

  • Title: The burnout: a silent saboteur in in vitro fertilization laboratories
    Authors: M. Basar, Tuba Düzcü
    Year: 2025

  • Title: E-Sağlık Okuryazarlık Düzeyinin Hastane Tercihi Öncesi ve Sonrasında Sosyal Medya Kullanımına Etkisi
    Authors: Ş. Küçük, Tuba Düzcü
    Year: 2025

  • Title: Hastalarda Beş Faktör Kişilik Modelinin Teknoloji Kabul Modeline Etkisinin Yapısal Eşitlik Modellemesiyle İncelenmesi
    Authors: N. Hacılar, Tuba Düzcü
    Year: 2024

  • Title: METAVERSE IN HEALTH FROM THE PERSPECTIVE OF HEALTH MANAGEMENT: A SYSTEMATIC RESEARCH
    Authors: Tuba Düzcü
    Year: 2024

  • Title: Hastaların e-sağlık okuryazarlık düzeylerinin hastane tercihinde sosyal medya kullanımına etkisi
    Authors: Ş. Küçük
    Year: 2024

Conclusion

Tuba Düzcü emerges as a dynamic scholar and educator who blends academic rigor with real-world insight in health management. With an interdisciplinary educational foundation and a career that spans academia and the pharmaceutical industry, she offers a unique perspective on healthcare transformation. Her research portfolio demonstrates a strong commitment to exploring innovative technologies and ethical dimensions in health services. She has made significant academic contributions through publications, international conferences, and participation in scholarly panels and workshops. Her administrative leadership further enhances her profile, showcasing her ability to influence institutional quality and educational development. Tuba’s work reflects a forward-thinking approach that aligns well with the evolving demands of global healthcare systems. She represents the integration of academic research, teaching excellence, and industry relevance. As a professional who continually engages with contemporary issues and contributes to academic growth, she stands out as a valuable figure in the field of health management and a promising candidate for recognition in academic and professional domains.

Krzysztof Jeziorski | Oncology | Best Researcher Award

Published on by World Top Scientists

Dr. Krzysztof Jeziorski | Oncology | Best Researcher Award 

Department of Gerontology and Public Health at National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland

Dr. Krzysztof Grzegorz Jeziorski, MD, PhD, is a distinguished Polish oncologist with a career spanning over four decades in clinical and academic medicine. He has served as Associate Professor and Senior Assistant at the Maria Skłodowska-Curie National Research Cancer Institute in Warsaw since 1988 and continues to contribute as a Clinical Trials Consultant at the National Institute of Geriatrics, Rheumatology and Rehabilitation. Dr. Jeziorski’s professional path is marked by leadership in gastrointestinal cancer research, extensive clinical trial involvement, and international academic collaborations. A former Dean of the Faculty of Health Sciences and Social Sciences, he combines deep clinical expertise with academic excellence. He has participated in fellowships across Europe, including at the University of Oxford and the University of Padova. Renowned for his commitment to advancing cancer research, he continues to enhance his knowledge through postgraduate studies and remains actively engaged in both practice and education.

Professional Profile 

Scopus Profile
ORCID Profile 

Education

Dr. Jeziorski earned his medical degree from the Medical University of Warsaw, completing the I Medical Faculty. He later pursued advanced specialization, obtaining first and second-grade specialties in General Medicine and Chemotherapy of Cancer from the Medical Centre of Postgraduate Education. His passion for oncology led him to further achieve a specialty in Clinical Oncology and a Doctorate in Medical Sciences. In 2009, he was awarded the prestigious Habilitation degree from the Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology. Dr. Jeziorski has continually enriched his education through prestigious fellowships and academic programs, including at the Universities of Oxford, Padova, Brussels, and Cambridge. He completed several key international training programs in epidemiology and public health. Recently, he completed postgraduate studies in Clinical Trial Methodology and is currently pursuing an MBA in Clinical Research and Biomedical Innovation Management at the Medical University of Warsaw, demonstrating his continued commitment to academic and professional growth.

Experience

Dr. Jeziorski brings a wealth of experience from clinical, academic, and administrative roles. Since 1988, he has been a leading figure at the Maria Skłodowska-Curie National Research Cancer Institute in Warsaw, serving as Associate Professor and senior assistant in the Outpatient Department for GI Cancers. He has also been a Clinical Trials Consultant at the National Institute of Geriatrics, Rheumatology and Rehabilitation since 2015. Earlier in his career, he worked with institutions like the Polish Academy of Sciences and served as Dean at the State Higher School of Pope John Paul II in Biała Podlaska. His clinical foundation was established at the Central Hospital of the Medical Academy in Warsaw. Dr. Jeziorski has managed over 20 international clinical trials as a Principal Investigator, contributing significantly to cancer research. His experience integrates scientific leadership, teaching, and hands-on patient care, making him a well-rounded and respected professional in medical oncology and research.

Awards and Honors

While a detailed list of awards is not provided in the curriculum vitae, Dr. Jeziorski’s academic journey includes several significant milestones that reflect a career of distinction. He received his Second Grade Specialty in Chemotherapy of Cancer with distinction, signaling outstanding academic and clinical performance. His international fellowships at elite institutions such as the University of Oxford, University of Padova, and University of Cambridge were awarded on a competitive basis and recognize his academic merit and research potential. Additionally, his long-term appointments at top-tier research institutes and his role as a Dean suggest institutional recognition of his expertise and leadership. Acceptance into high-profile postgraduate and international research training programs—including the Erasmus Summer Program and WHO/IDF seminars—further highlight his professional standing. His ongoing pursuit of an MBA in Clinical Research reflects both personal ambition and recognition of his evolving role in biomedical innovation and management.

Research Focus on Oncology

Dr. Jeziorski’s primary research focus lies in the field of gastrointestinal oncology, where he has made sustained contributions through clinical trials and academic leadership. He has acted as Principal Investigator in over 20 international clinical trials and participated in numerous additional studies as a Sub-Investigator. His research emphasizes improving therapeutic strategies for gastrointestinal neoplasms, with a strong interest in translating scientific findings into clinical practice. Dr. Jeziorski combines rigorous methodological training with deep clinical insight, as demonstrated by his postgraduate studies in clinical trial methodology and his continued education in research management. His international fellowships enriched his approach to evidence-based medicine and interdisciplinary collaboration. Throughout his career, he has actively worked to integrate public health perspectives and epidemiology into oncology research. By maintaining roles in both clinical care and research, Dr. Jeziorski ensures his work remains patient-centered, innovative, and aligned with global advances in cancer treatment.

Publications Top Notes

  • Title: Artificial Intelligence in Oncology

    • Authors: Krzysztof Jeziorski, Robert Olszewski

    • Year: 2024

  • Title: Lost in Communication: Do Family Physicians Provide Patients with Information on Preventing Diet-Related Diseases?

    • Authors: Robert Olszewski, Justyna Obiała, Karolina Obiała, Jakub Owoc, Małgorzata Mańczak, Klaudia Ćwiklińska, Magdalena Jabłońska, Paweł Zegarow, Jolanta Grygielska, Marzena Jaciubek, et al.

    • Year: 2022

  • Title: Hyperthermia in Rheumatic Diseases. A Promising Approach?

    • Author: Krzysztof Jeziorski

    • Year: 2018

  • Title: HER2 Status in GI Adenocarcinoma (TRIO-013/LOGiC Trial)

    • Authors: Press M.F., Ellis C.E., Gagnon R.C., Jeziorski K., et al.

    • Year: 2017

  • Title: Preservation of Duodenal Passage and Quality of Life After Gastrectomy

    • Authors: Olesiński T., Szpakowski M., Saramak P., Rutkowski A., Jeziorski K.

    • Year: 2017

  • Title: Rheumatic and Oncological Diseases – Common Challenges

    • Author: Krzysztof Jeziorski

    • Year: 2017

  • Title: Lapatinib + Chemotherapy in HER2+ GI Cancers (LOGiC Trial)

    • Authors: Hecht J.R., Bang Y.-J., Qin S.K., Jeziorski K., et al.

    • Year: 2016

  • Title: Preoperative Chemoradiation vs Short-Course Therapy in Rectal Cancer

    • Authors: Bujko K., Wyrwicz L., Rutkowski A., Jeziorski K., et al.

    • Year: 2016

  • Title: Validation of QLQ-GINET21 for GI Neuroendocrine Tumors

    • Authors: Yadegarfar G., Friend L., Jeziorski K., et al.

    • Year: 2013

  • Title: Efficacy of Y-90 DOTATATE in GEP-NETs – Phase II Study

    • Authors: Cwikla J.B., Sankowski A., Jeziorski K.G., et al.

    • Year: 2009

  • Title: Radiological Efficacy of 90Y-DOTATATE in Midgut NETs

    • Authors: Cwikla J.B., Sankowski A., Jeziorski K.G., et al.

    • Year: 2009

  • Title: Abscesses After Splenectomy in Gastric/Cardia Cancer Surgery

    • Authors: Szpakowski M., Olesiński T., Jeziorski K., et al.

    • Year: 2007

  • Title: Chemotherapy for Hepatocellular and Biliary Duct Cancers

    • Author: Krzysztof Jeziorski

    • Year: 2007

  • Title: Imaging of Gastroenteropancreatic NETs – Polish Center Experience

    • Authors: Cwikla J.B., Nasierowska-Guttmejer A., Jeziorski K.G., et al.

    • Year: 2007

  • Title: Leptomeningeal Metastases of EGJ Adenocarcinoma – Case Report

    • Authors: Olesiński T., Jeziorski K., Szawłowski A.

    • Year: 2007

Conclusion

Dr. Krzysztof Jeziorski exemplifies a distinguished researcher and clinician whose contributions to gastrointestinal oncology span over four decades. His involvement in high-impact, multi-center clinical trials, coupled with authorship in internationally recognized journals such as Journal of Clinical Oncology, Annals of Oncology, and British Journal of Cancer, highlights both the breadth and relevance of his work. He has consistently collaborated with global experts and participated in pivotal studies that influence cancer treatment protocols. His recent engagement with artificial intelligence in oncology indicates a forward-thinking and adaptive research approach. Although citation metrics for many of his publications are not readily available, the scope, continuity, and quality of his work speak to his lasting impact on cancer research. Dr. Jeziorski’s blend of clinical excellence, academic leadership, and international collaboration positions him as a highly deserving candidate for the Best Researcher Award, with a legacy that bridges science, innovation, and patient-centered care.